Mon, Jul 28, 2014, 6:19 AM EDT - U.S. Markets open in 3 hrs 11 mins


% | $
Click the to save as a favorite.

Arena Pharmaceuticals, Inc. Message Board

mario_themario 6 posts  |  Last Activity: Jul 7, 2014 3:16 PM Member since: May 23, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mario_themario by mario_themario Jul 7, 2014 3:16 PM Flag

    By selling at 5.85 he saved $134,115 at today's price. Who said Jack was stupid.

  • Reply to

    More Nonsense from Barrons and MS dweebs

    by squeezetracker Jun 27, 2014 12:51 PM
    mario_themario mario_themario Jun 28, 2014 12:34 PM Flag

    I don't get how they're the most "expensive stock". Looking at forward P/E they are the cheapest in the group. Another ignored metric is debt with MPEL having by far the lowest debt load in the group + forget about MGM's debt which is enormous. Now the ANALysts are touting the great comps in Vegas so I guess that will continue going forward and Macau will sink, NOT, yet they keep harping on the VIP segment, the smoking ban, the credit issue, etc, none of which has impacted MPEL thus far as earnings continue to impress. These clowns are positioning their clients into the right stocks by jaw boning stocks like MPEL down, to try + get the price down so their clients can get in cheaper.

  • Reply to

    Isn't MO a bit overextended here?

    by archmage10101 Jun 19, 2014 1:32 PM
    mario_themario mario_themario Jun 19, 2014 2:09 PM Flag

    I would normally say yes but the "pending merger" has driven up pps across the sector, an anomaly. Check the P/E's of LO + RAI compared to MO and you get a different picture. Bonnie says LO buy out at 80!

  • mario_themario mario_themario Jun 13, 2014 7:41 PM Flag

    Paying a divvy at this stage is irresponsible. They need to maintain sufficient funds to continue to support their pipe and to wait until B starts generating enough cash flow to sustain the company. The shorts would not be affected with a token divvy. They would just have to pay that amount for each share short, aka, .05 divvy, 1000 shares short, $50 to the broker. They are better off status quo + hopefully not have to go for another secondary to support the company.

  • Reply to


    by sharonconk Jun 11, 2014 5:34 PM
    mario_themario mario_themario Jun 11, 2014 5:37 PM Flag

    I agree but he should have given some light on WHEN we'll expect to see the B/Phen data. Also liked that they mentioned Glaxo as a potential suitor and followed up with its a buy at these levels. Adam Fartstain, the expert in biotech, will come out with a hit piece soon after he blew the OREX call.
    He also said Eisai has said nothing about a buyout. Overall a positive news bite for longs.

  • Reply to

    Added @ 34.01....careful....

    by edwardejenkins May 7, 2014 10:07 AM
    mario_themario mario_themario May 7, 2014 1:25 PM Flag

    Just bought another 1K shares at 33.40. Expect a good call + some analysts like LVS + WYNN better but look at the forward P/E's of the 3 and net cash positions.

4.77-0.08(-1.65%)Jul 25 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Puma Biotechnology, Inc.
NYSEFri, Jul 25, 2014 4:01 PM EDT Inc.
NasdaqGSFri, Jul 25, 2014 3:59 PM EDT